Citric Acid → {1-[4-(8-Chloro-2-ethoxy-quinolin-4-yloxy)-2-(1-cyclopropoxysulfonylaminocarbonyl-2-ethyl-cyclopropylcarbamoyl)-pyrrolidine-1-carbonyl]-2,2-dimethyl-propyl}-carbamic acid 1-trifluoromethyl-cyclobutyl ester

HRID 1893685Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1893685
[Cl:1][C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:11]=1[N:10]=[C:9]([O:12][CH2:13][CH3:14])[CH:8]=[C:7]2[O:15][CH:16]1[CH2:20][N:19]([C:21](=[O:39])[CH:22]([NH:27][C:28]([O:30][C:31]2([C:35]([F:38])([F:37])[F:36])[CH2:34][CH2:33][CH2:32]2)=[O:29])[C:23]([CH3:26])([CH3:25])[CH3:24])[CH:18]([C:40]([NH:42][C:43]2([C:48]([OH:50])=O)[CH2:45][CH:44]2[CH2:46][CH3:47])=[O:41])[CH2:17]1.C(N([CH:57]([CH3:59])[CH3:58])C(C)C)C.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C1([O:87][S:88](=[O:91])(=[O:90])[NH2:89])CC1.C1CCN2C(=NCCC2)CC1.C(O)(=O)CC(CC(O)=O)(C(O)=O)O>CN(C=O)C>[F:38][C:35]([F:36])([F:37])[C:31]1([O:30][C:28](=[O:29])[NH:27][CH:22]([C:21]([N:19]2[CH2:20][CH:16]([O:15][C:7]3[C:6]4[C:11](=[C:2]([Cl:1])[CH:3]=[CH:4][CH:5]=4)[N:10]=[C:9]([O:12][CH2:13][CH3:14])[CH:8]=3)[CH2:17][CH:18]2[C:40](=[O:41])[NH:42][C:43]2([C:48]([NH:89][S:88]([O:91][CH:57]3[CH2:59][CH2:58]3)(=[O:90])=[O:87])=[O:50])[CH2:45][CH:44]2[CH2:46][CH3:47])=[O:39])[C:23]([CH3:25])([CH3:26])[CH3:24])[CH2:34][CH2:33][CH2:32]1

Komponenten

8

Versuchsvorschrift

To 1-({4-(8-chloro-2-ethoxy-quinolin-4-yloxy)-1-[3,3-dimethyl-2-(1-trifluoromethyl-cyclobutoxycarbonylamino)-butyryl]-pyrrolidine-2-carbonyl}-amino)-2-ethyl-cyclopropanecarboxylic acid (110 mg, 0.15 mmol) in DMF (3 mL, 0.05 M) was added i-Pr2EtN (90 μL, 0.38 mmol) and HATU (86 mg, 0.23 mmol) and stirred 1 h at rt. To the reaction mixture at rt was added sulfamic acid cyclopropyl ester (46 mg, 0.30 mmol) and DBU (90 μL, 0.60 mmol). The reaction was stirred 17 h at rt, and then added to 5% aq citric acid and extracted with ethyl acetate. The combined organic extracts were washed water, and brine, and subsequently dried over magnesium sulfate. Concentration, followed by purification by reverse phase HPLC and lyophilization gave {1-[4-(8-chloro-2-ethoxy-quinolin-4-yloxy)-2-(1-cyclopropoxysulfonylaminocarbonyl-2-ethyl-cyclopropylcarbamoyl)-pyrrolidine-1-carbonyl]-2,2-dimethyl-propyl}-carbamic acid 1-trifluoromethyl-cyclobutyl ester (20 mg, 16% yield) as a white powder. 1H NMR (CD3OD, 500 MHz) δ 9.18 (s, 1H), 7.95 (d, 1H), 7.70 (d, 1H), 7.20 (dd, 1H), 6.48 (s, 1H), 5.4 (br s, 1H), 4.45-4.6 (m, 4H), 4.2-4.3 (m, 2H), 2.58-2.62 (m, 1H), 2.2-2.4 (m, 4H), 1.5-1.7 (m, 4H), 1.43 (t, 3H), 1.2-1.3 (m, 3H) 1.2 (dd, 2H), 1.1-0.9 (m, 13H), 0.85 (m, 2H). LCMS found 846.00 [M+H]+.

Aufarbeitung

  1. stirringThe reaction was stirred 17 h at rt
  2. extractionextracted with ethyl acetate
  3. washThe combined organic extracts were washed water, and brine
  4. dry with materialsubsequently dried over magnesium sulfate
  5. concentrationConcentration
  6. customfollowed by purification by reverse phase HPLC and lyophilization

Quellen und Nachweise

ORD-Eintrag
ord-b1d7043c55b348c0b36b42a731d0a76a
Quelldatensatz
uspto-grants-2013_08
Patentnummer
US08513186B2

Notizen zur Reaktion

Wird geladen…